197 related articles for article (PubMed ID: 20721822)
1. European Generic Medicines Association (EGA)--16th Annual Conference.
Kennedy B
IDrugs; 2010 Aug; 13(8):530-3. PubMed ID: 20721822
[TBL] [Abstract][Full Text] [Related]
2. Generics, Supergenerics and Patent Strategies--SMi's 13th Annual Meeting.
Edwards C
IDrugs; 2010 Jul; 13(7):433-6. PubMed ID: 20582864
[TBL] [Abstract][Full Text] [Related]
3. 13th EGA annual conference. Challenges in the European and global environment for the generic medicines industry.
Kuhrt K
IDrugs; 2007 Aug; 10(8):549-53. PubMed ID: 17665329
[No Abstract] [Full Text] [Related]
4. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 2.
Kuhrt K
IDrugs; 2009 Dec; 12(12):765-9. PubMed ID: 19943218
[TBL] [Abstract][Full Text] [Related]
5. Joint 24th Medicines for Europe and 21st International Generic and Biosimilars Association (IGBA) Annual Conference (June 13-15, 2018 - Budapest, Hungary).
Cross G
Drugs Today (Barc); 2018 Aug; 54(8):499-505. PubMed ID: 30209444
[TBL] [Abstract][Full Text] [Related]
6. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
7. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1.
Kuhrt K; Chace-Ortiz M
IDrugs; 2009 Dec; 12(12):760-4. PubMed ID: 19943217
[TBL] [Abstract][Full Text] [Related]
8. Generic medicines: solutions for a sustainable drug market?
Dylst P; Vulto A; Godman B; Simoens S
Appl Health Econ Health Policy; 2013 Oct; 11(5):437-43. PubMed ID: 23846572
[TBL] [Abstract][Full Text] [Related]
9. The Pharma Summit 2010: competing in the future healthcare system.
Kibble A
IDrugs; 2010 Apr; 13(4):228-31. PubMed ID: 20373249
[TBL] [Abstract][Full Text] [Related]
10. Business of biosimilars - 14th annual conference (October 15-17, 2013 - Boston, Massachusetts, USA).
Bourgoin A
Drugs Today (Barc); 2013 Dec; 49(12):799-801. PubMed ID: 24524098
[TBL] [Abstract][Full Text] [Related]
11. A report from the 16th Annual IGPA Conference (December 9-11, 2013 - Brussels, Belgium).
Bowman M
Drugs Today (Barc); 2014 Jan; 50(1):101-8. PubMed ID: 24524106
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Italian generic medicines retail market: recommendations to enhance long-term sustainability.
Dylst P; Vulto A; Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):33-42. PubMed ID: 25138241
[TBL] [Abstract][Full Text] [Related]
13. Contemporary generic market in Japan - key conditions to successful evolution.
Jakovljevic MB; Nakazono S; Ogura S
Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):181-94. PubMed ID: 24450984
[TBL] [Abstract][Full Text] [Related]
14. World Generic Medicines Congress Americas--a Health Network Communications Conference. 18-21 November 2008, Washington DC, USA.
Bowman M
IDrugs; 2009 Feb; 12(2):92-4. PubMed ID: 19204881
[No Abstract] [Full Text] [Related]
15. The importance of being first: evidence from Canadian generic pharmaceuticals.
Hollis A
Health Econ; 2002 Dec; 11(8):723-34. PubMed ID: 12457372
[TBL] [Abstract][Full Text] [Related]
16. A trade agreement's impact on access to generic drugs.
Shaffer ER; Brenner JE
Health Aff (Millwood); 2009; 28(5):w957-68. PubMed ID: 19706626
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical Pricing and Market Access Outlook Europe 2010-HealthNetwork Communications' fourth annual conference. 24-25 March 2010, London, UK.
Ogbighele E
IDrugs; 2010 May; 13(5):317-20. PubMed ID: 20432188
[TBL] [Abstract][Full Text] [Related]
18. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
Cheng N; Banerjee T; Qian J; Hansen RA
J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
[TBL] [Abstract][Full Text] [Related]
19. Regulation of biogenerics: a survey of viewpoints.
Nieminen O; Nordström K
BioDrugs; 2004; 18(6):399-406. PubMed ID: 15571423
[TBL] [Abstract][Full Text] [Related]
20. On macroeconomic characteristics of pharmaceutical generics and the potential for manufacturing and consumption under fuzzy conditions.
Gascón F; de la Fuente D; Puente J; Lozano J
Artif Intell Med; 2007 Nov; 41(3):223-35. PubMed ID: 17719212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
